Stocks and Investing
Stocks and Investing
Mon, November 1, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Jonathan Chang Initiated (VINC) at Buy and Held Target at $24 on, Nov 1st, 2021
Jonathan Chang of SVB Leerink, Initiated "Vincerx Pharma, Inc." (VINC) at Buy and Held Target at $24 on, Nov 1st, 2021.
Jonathan has made no other calls on VINC in the last 4 months.
There are 3 other peers that have a rating on VINC. Out of the 3 peers that are also analyzing VINC, 0 agree with Jonathan's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Jonathan
- Yale Jen of "Laidlaw & Co." Initiated at Strong Buy and Held Target at $30 on, Monday, September 13th, 2021
- Kalpit Patel of "B. Riley Securities" Initiated at Strong Buy and Held Target at $26 on, Wednesday, August 25th, 2021
- Geulah Livshits of "Chardan Capital" Maintained at Strong Buy with Decreased Target to $30 on, Friday, August 13th, 2021
Contributing Sources